← Leaderboards
Douglas L. Leslie
Yale University
$7,297,569
Attributed
$8,750,946
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2006–24$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,381,660 · 5
AHRQ$2,369,286 · 2
By mechanism
R01$7,836,711 · 6
RC1$914,235 · 1
Top collaborators
- Cynthia H Chuang3 shared
- David S Mandell3 shared
Most similar at Yale University
Same institution · by research overlap
- Kathleen M Carroll$45,607,051
- Frederick Lewis Altice$47,021,698
- Ismene L Petrakis$10,363,765
- Bruce James Rounsaville$12,542,837
- Rajita Sinha$53,551,446
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectServicesPoliciesCharacteristicsMental HealthFamilyCostMedicaidProgramsUnited StatesInsuranceCaringSymptomsHealthcareHealth Services AccessibilityDevelopmental Disease/DisorderDatabasesPatternMental DisordersComplexAutistic DisorderAutism Spectrum DisorderInsurance CarriersChild
Grant awards (21)
COVID-19, health systems and vulnerable populations: Policies affecting maternal opioid use during pregnancy$399,998
R01 · FY2024 · HS · contact PI
COVID-19, health systems and vulnerable populations: Policies affecting maternal opioid use during pregnancy$400,000
R01 · FY2023 · HS · contact PI
COVID-19, health systems and vulnerable populations: Policies affecting maternal opioid use during pregnancy$378,365
R01 · FY2022 · HS · contact PI
Opioid use disorders in adolescents: predictors of treatment and outcomes$569,985
R01 · FY2021 · DA · contact PI
The effects of state policies on opioid use disorders in pregnant women: prevalence, treatment and outcomes$396,441
R01 · FY2021 · HS · contact PI
Opioid use disorders in adolescents: predictors of treatment and outcomes$567,298
R01 · FY2020 · DA · contact PI
The effects of state policies on opioid use disorders in pregnant women: prevalence, treatment and outcomes$394,482
R01 · FY2020 · HS · contact PI
Opioid use disorders in adolescents: predictors of treatment and outcomes$724,242
R01 · FY2019 · DA · contact PI
The effects of state policies on opioid use disorders in pregnant women: prevalence, treatment and outcomes$400,000
R01 · FY2019 · HS · contact PI
The Effects of Medicaid Waivers on Autism Service Use and Expenditures$527,951
R01 · FY2018 · MH · contact PI
The Effects of Medicaid Waivers on Autism Service Use and Expenditures$525,745
R01 · FY2017 · MH · contact PI
The Effects of Medicaid Waivers on Autism Service Use and Expenditures$674,696
R01 · FY2016 · MH · contact PI
The Effects of State and Federal Insurance Policies on Quality of Care for Autism$424,128
R01 · FY2014 · MH · contact PI
The Effects of State and Federal Insurance Policies on Quality of Care for Autism$406,574
R01 · FY2013 · MH · contact PI
The Effects of State and Federal Insurance Policies on Quality of Care for Autism$450,534
R01 · FY2012 · MH · contact PI
Economic Production Functions of Schizophrenia Treatment$417,851
RC1 · FY2010 · MH · contact PI
Economic Production Functions of Schizophrenia Treatment$496,384
RC1 · FY2009 · MH · contact PI
Patterns of Service Use and Costs Associated with Autism$115,769
R01 · FY2008 · MH · contact PI
Patterns of Service Use and Costs Associated with Autism$28,955
R01 · FY2008 · MH · contact PI
Patterns of Service Use and Costs Associated with Autism$158,148
R01 · FY2007 · MH · contact PI
Patterns of Service Use and Costs Associated with Autism$293,400
R01 · FY2006 · MH · contact PI